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Abstract
The Anatomical Therapeutic Chemical (ATC) classification system, recommended by the World Health Organization,
categories drugs into different classes according to their therapeutic and chemical characteristics. For a set of query
compounds, how can we identify which ATC-class (or classes) they belong to? It is an important and challenging problem
because the information thus obtained would be quite useful for drug development and utilization. By hybridizing the
informations of chemical-chemical interactions and chemical-chemical similarities, a novel method was developed for such
purpose. It was observed by the jackknife test on a benchmark dataset of 3,883 drug compounds that the overall success
rate achieved by the prediction method was about 73% in identifying the drugs among the following 14 main ATC-classes:
(1) alimentary tract and metabolism; (2) blood and blood forming organs; (3) cardiovascular system; (4) dermatologicals; (5)
genitourinary system and sex hormones; (6) systemic hormonal preparations, excluding sex hormones and insulins; (7) anti-
infectives for systemic use; (8) antineoplastic and immunomodulating agents; (9) musculoskeletal system; (10) nervous
system; (11) antiparasitic products, insecticides and repellents; (12) respiratory system; (13) sensory organs; (14) various.
Such a success rate is substantially higher than 7% by the random guess. It has not escaped our notice that the current
method can be straightforwardly extended to identify the drugs for their 2
nd-level, 3
rd-level, 4
th-level, and 5
th-level ATC-
classifications once the statistically significant benchmark data are available for these lower levels.
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Introduction
Nowadays, the Anatomical Therapeutic Chemical (ATC)
classification system, recommended by the World Health Orga-
nization (WHO), is the most widely recognized classification
system for drugs. This classification system divides drugs into
different groups according to the organ or system on which they
act and/or their therapeutic and chemical characteristics.
Accordingly, the ATC classification is very helpful for studying
utilization of drugs and categorizing them according to different
purposes, therapeutic properties, chemical and pharmacological
properties (see Report of the WHO Expert Committee, 2005;
World Health Organ Tech Rep, Ser:1–119). In the ATC
classification system, drugs are classified into 14 main classes
(http://www.whocc.no/atc/structure_and_principles/). In order
to understand this kind of complicated classification system, some
efforts have been made [1,2]. In a pioneer study, Gurulingappa et
al. [2] proposed a method to study the ATC-classification system
by combining the information extraction and machine learning
techniques. However, their method can be used to identify the
drug compounds only within the class of ‘‘Cardiovascular
System’’, one of the 14 main ATC classes.
During the past decade, many compound databases, such as
KEGG (Kyoto Encyclopedia of Genes and Genomes) [3,4], have
been established. From these databases many compounds and
their properties can be acquired. Such abundant informations
provide an opportunity to analyze ATC classification system in
greater detail. Encouraged by the successes of using machine
learning and data mining methods to investigate complicated
problems in a variety of biological areas [5,6,7,8,9], the present
study was initiated in an attempt to develop a powerful method by
which one can identify query drugs compound among all their 14
posible main classes.
According to a recent comprehensive review [10], to establish a
really useful statistical predictor for a biological system, we need to
consider the following procedures: (i) construct or select a valid
benchmark dataset to train and test the predictor; (ii) formulate the
samples concerned with an effective mathematical expression that
can truly reflect their intrinsic correlation with the target to be
predicted; (iii) introduce or develop a powerful algorithm (or
engine) to operate the prediction; (iv) properly perform cross-
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the predictor. Below, let us describe how to deal with these steps
one by one.
Materials and Methods
Recently, the information of protein-protein interactions have
been used for predicting various attributes of proteins (see, e.g.,
[11,12,13]), implying that interactive proteins are more likely to
share common biological functions [11] than non-interactive ones
[14]. Likewise, it is more likely that two interactive drug
compounds may have the similar biological function. Actually, it
is generally accepted that compounds with similar physicochem-
ical properties often involve in similar biological activities [1].
Accordingly, it is reasonable to assume that the interactive drugs
may likely belong to the same ATC-class, and so do those drugs
with similar structures. Based on such rational, let us construct the
following benchmark to develop a new method for identifying the
ATC-classes of drugs.
Benchmark Dataset
The dataset for drugs was obtained from the public available
database KEGG [3,4] at ftp://ftp.genome.jp/pub/kegg/
medicus/drug/drug (June, 2011). There are totally 9,758 drugs.
After excluding those without the information of ATC-codes, the
remaining are 4,376 drug samples, from which further screening
was performed to remove those without the information of both
chemical-chemical interactions and chemical-chemical similarities.
After the above winnowing procedures, we finally obtained the
benchmark dataset S containing 3,883 drugs classified into 14
main ATC-classes, as can be formulated by
S~S1|S2|S3|S4|S5|S6|   |S14 ð1Þ
where S1 represents the subset for the 1
st main ATC class called
‘‘Alimentary tract and metabolism’’, S2 the subset for the 2
nd
main ATC class ‘‘Blood and blood forming organs’’, S3 the subset
for the 3
rd main ATC class ‘‘Cardiovascular system’’, and so forth
(cf. Table 1); while | represents the symbol for ‘‘union’’ in the set
theory. For convenience, hereafter let us just use C1, C2, C3,… ,
C14 as the tags of the 14 classes. A breakdown of the 3,883 drugs
into the 14 main ATC-classes is given in Table 1. For the codes of
these drugs in each of the 14 classes, see Supporting Information
S1. During the course of constructing the benchmark dataset,
the information from http://www.genome.jp/kegg-bin/get_htext?
br08303.keg was used that collected the drug compounds and their
ATC classification information from http://www.whocc.no/
atc_ddd_index/ and provided the ATC code for each drug.
Because some drugs may belong to more than one main ATC-
class, like the case in dealing with proteins with multiple location
sites [15,16,17], it is instructive to introduce the concept of the
‘‘virtual drugs’’ as illustrated as follows. A drug compound
belonging to two different ATC-classes will be counted as 2
virtual samples even though they have an identical chemical
structure; if belonging to three different classes, 3 virtual samples;
and so forth. Accordingly, the total number of the different virtual
drug samples is generally greater than that of the total different
structural drug samples. Their relationship can be formulated as
follows [18]
N(vir)~N(struct)z
X M
Q~1
Q{1 ðÞ N(Q) ð2Þ
where N(vir) is the number of total different virtual drug samples
in S, N(struct) the number of total different structural drugs,
N(1) the number of drugs belonging to one ACT-class, N(2) the
number of drugs belonging to two ATC-classes, and so forth; while
M is the number of total main ACT-classes (for the current case,
M~14 (cf. Table 1).
For the current 3,883 drugs in S, 3,295 occur in one class, 370
in two classes, 110 in three classes, 37 in four classes, 27 in five
classes, 44 in six classes, and none in seven or more classes
(Figure 1). Substituting these data into Eq.1, we have
N(vir)~N(struct)z(1{1)|3295z(2{1)|370
z(3{1)|110z(4{1)|37z(5{1)|27
z(6-1)|44z
X 14
L~7
(L{1)|0
~3883z370z220z111z108z220~4912
ð3Þ
which is fully consistent with the figures in Table 1 and the data
in Supporting Information S1.
Prediction Based on Chemical-Chemical Interactions
Based on the fact that the interactive compounds often involve
in similar biological activities [11], it is feasible to predict the ATC-
class of a query drug using the information of chemical-chemical
interactions, as described below.
STITCH (Search tool for interactions of chemicals) [19] is a
large database containing known and predicted interactions
between chemicals and between proteins derived from experi-
ments, literature and other databases. We downloaded the
information of chemical-chemical interactions from http://stitch.
embl.de:8080/download/chemical_chemical.links.v2.0.tsv.gz.
Each of these interactions was evaluated by a confidence score,
ranging from 1 to 1000, to reflect the likelihood of its occurrence.
For any two drugs d1 and d2, their interaction confidence score was
denoted by Qi(d1,d2). Particularly, if the interaction between d1
and d2 does not exist in STITCH, their interaction confidence
score was set as zero, i.e., Qi(d1,d2)~0.
Suppose that a training dataset S
train consists of n drugs
dk(k~1,2,    , n), and that the 14 main ATC-classes are denoted
by C~½C1,C2,   ,C14 , where C1 represents ‘‘Alimentary tract
and metabolism’’, C2 ‘‘Blood and blood forming organs’’, and so
forth (see Table 1). The ATC-classes of any drug di can be
formulated as
C(di)~ ci,1, ci,2,    , ci,14
no
(i~1, 2,    , n) ð4Þ
where
ci,j~
1, if di belongs to Cj
0, otherwise
 
(i~1,2,    , n; j~1,2,    , 14)ð5Þ
According to the chemical-chemical interaction approach, the
likelihood for a query drug d belonging to Cj, denoted as
P(i) d.Cj
  
, can be calculated by
P(i) d.Cj
  
~maxdk[StrainQi d,dk ðÞ :ck,j (j~1,2,   ,14) ð6Þ
where dk[S
train means that dk is an element of the training dataset
ATC Classification of Drugs
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train. According Eq.6, the likelihood that d belongs to Cj can be
formulated as the maximum of the interaction confidence scores
between d and those drugs that belong to Cj in the training dataset
S
train. Obviously, the larger the score is, the more likely that d
belongs to Cj. When P(i) d.Cj
  
~0, it means that the
probability for the drug d belonging to the class Cj is zero. Given
a query drug compound d, suppose the outcome derived from
Eq.6 is
P(i) d.C8 ðÞ wP(i) d.C1 ðÞ wP(i) d.C2 ðÞ w   
wP(i) d.C14 ðÞ w0
ð7Þ
which means that the highest probability for the drug d belonging
to the ATC-class is C8 (‘‘Antineoplastic and immunomodulating
agents’’), followed by C1 (‘‘Alimentary tract and metabolism’’), and
so forth (cf. Table 1). If there is a tie between two terms in Eq.7,
then the probabilities for the drug belonging to the two
corresponding classes are the same. But this kind of tie case rarely
happened.
Note that the outcome of Eq.6 might turn out to be trivial, i.e.,
P(i) d.Cj
  
~0( j~1,2,   ,14) ð8Þ
indicating that no chemical-chemical interaction exists for the
query drug d in the training dataset S
train; i.e.,
Qi d,dk ðÞ ~0( f o r dk[S
train or k~1,2,    , n) ð9Þ
Under such a circumstance, no meaningful result would be
obtained by the ‘‘interaction-based’’ method, and we should
instead use the ‘‘similarity-based method as described in the next
section.
Prediction Based on Chemical-Chemical Similarities
Likewise, based on the fact that the compounds with similar
physicochemical properties often have the same biological
activities [1], we can also use the information of chemical-
chemical similarities as another feasible avenue to predict the
ATC-class for a query drug. To realize this, let us first introduce
how to use graphical representation to measure the similarity
between two drug compounds.
Graphical approaches can provide intuitive pictures and useful
insights for studying and analyzing complicated biological systems,
as demonstrated by many studies on a series of important
biological topics (see, e.g., [20,21,22,23,24,25,26,27,28,29,30]).
Here, a special graphic approach was utilized to estimate the
Table 1. Breakdown of the benchmark dataset S according to the 14 main ATC classes.
Tag The 1
st-level ATC class Number of drugs
C1 Alimentary tract and metabolism 540
C2 Blood and blood forming organs 133
C3 Cardiovascular system 591
C4 Dermatologicals 421
C5 Genito-urinary system and sex hormones 248
C6 Systemic hormonal preparations, excluding sex hormones and insulins 126
C7 Antiinfectives for systemic use 521
C8 Antineoplastic and immunomodulating agents 232
C9 Musculo-skeletal system 208
C10 Nervous system 737
C11 Antiparasitic products, insecticides and repellents 127
C12 Respiratory system 427
C13 Sensory organs 390
C14 Various 211
Number of total virtual drugs N(vir) 4,912
a
Number of total structural different drugs N(struct) 3,883
b
aSee Eqs.2–3 for the definition about the number of virtual drugs, and its relation with the number of structural different drugs.
bOf the 3,883 structural different drugs, 3,295 belong to one class, 370 to two classes, 110 to three classes, 37 to four classes, 27 to five classes, and 44 to six classes. See
Supporting Information S1 for the detailed drug codes listed in each of 14 ATC-classes.
doi:10.1371/journal.pone.0035254.t001
Figure 1. An illustration to show the distribution about the
numbers of ATC-classes a same drug may belong to. For the
3,883 drugs in S, 3,295 belong to one class, 370 to two classes, 110 to
three classes, 37 to four classes, 27 to five classes, 44 to six classes, and
none to seven or more classes.
doi:10.1371/journal.pone.0035254.g001
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means to measure the similarity of two compounds via their graph
representations. Since each chemical structure can be easily
represented by a 2D (two-dimensional) graph where vertices stand
for atoms and edges for bonds between them, the similarity of two
compounds can be estimated by the Jaccard coefficient [32,33]
based on their maximum common subgraph. The similarity scores
between compounds by this method can be obtained from the
website at http://www.genome.jp/ligand-bin/search_compound.
According to the graphical method by Hattori et al. [31], given two
drug compounds d1 and d2, their similarity score was denoted by
Qs(d1,d2). When the similarity score between d1 and d2 does not
exist in http://www.genome.jp/ligand-bin/search_compound,
their similarity was set as zero; i.e., Qs(d1,d2)~0.
Thus, the prediction method based on the chemical-chemical
similarities can be formulated in a way almost completely parallel
to that of the chemical-chemical interactions as done in the
preceding section.
Now, instead of Eq.6, we have
P(s) d.Cj
  
~maxdk[StrainQs d,dk ðÞ :ck,j (j~1,2,   ,14) ð10Þ
where the superscript and subscript ‘‘s’’ stands for the 1
st letter of
‘‘similarity’’, implying that the calculation is now based on
‘‘chemical-chemical similarity’’ instead of ‘‘chemical-chemical
interaction’’ as done in Eq.6.
Prediction by Integrating the Interaction-Based and
Similarity-Based Methods
Given a query drug compound d, when the integrated method
was used to identify its ATC-class, the prediction involved the
following two steps.
Step 1. The interaction-based method (cf. Eq.6) was first
applied to identify its ATC-class.
Step 2. If the probabilities thus obtained for the drug
belonging to all the 14 ATC-classes were zero as indicated in
Eq.8, meaning no meaningful results were obtained at all, then
the prediction would continue using the similarity-based method
(cf. Eq.10).
Jackknife Cross-Validation
In statistical prediction, the following three cross-validation
methods are often used to examine the quality of a predictor:
independent dataset test, subsampling (or k-fold crossover) test,
and jackknife test [34]. However, of the three test methods, the
jackknife test is deemed the least arbitrary that can always yield a
unique result for a given benchmark dataset [35]. The reasons are
as follows. (i) For the independent dataset test, although all the
samples used to test a predictor are outside the training dataset
used to train the prediction engine so as to exclude the ‘‘memory’’
effect or bias, the way of how to select the independent samples for
testing the predictor could be quite arbitrary unless the number of
independent samples is sufficiently large. This kind of arbitrariness
might lead to completely different conclusions. For instance, a
predictor achieving a higher success rate than the other for a given
independent testing dataset might not able to keep so when tested
by another independent testing dataset [34]. (ii) For the
subsampling (or k-fold crossover) test, the concrete procedure
usually used in literatures was the 5-fold, 7-fold or 10-fold cross-
validation. The problem with this kind of subsampling test was
that the number of possible selections in dividing a benchmark
dataset would be an astronomical figure even for a very simple
dataset, as elucidated in [35] and demonstrated by Eqs.28–30 in
[10]. Therefore, in any practical subsampling cross-validation
tests, only an extremely small fraction of the possible selections
were taken into account. Since different selections would always
yield different results even for a same benchmark dataset and a
same predictor, the subsampling test could not avoid the
arbitrariness either. A test method unable to generate a unique
outcome should not be deemed as a good one. (iii) In the jackknife
test, all the samples in the benchmark dataset will be singled out
one-by-one and tested by the predictor trained by the remaining
samples. During the process of jackknifing, both the training
dataset and testing dataset are actually open, and each sample will
be in turn moved between the two. The jackknife test can exclude
the ‘‘memory’’ effect. Also, the arbitrariness problem as mentioned
above for the independent dataset test and subsampling (or k-fold
crossover) test can be avoided because the outcome obtained by
the jackknife cross-validation is always unique for a given
benchmark dataset. Accordingly, the jackknife test has been
widely recognized and increasingly adopted by many investigators
to examine the quality of various predictors (see, e.g.,
[36,37,38,39,40,41,42,43,44,45,46,47]). Accordingly, in this study
we are to use the jackknife test to examine the prediction quality as
well.
Accuracy Measurement
For any given set of query drugs, we can obtain a series of
candidate ATC-classes using the aforementioned prediction
methods. Ranked by the likelihood according to their descending
order, the prediction accuracy can be defined as
ACj~
CPj
N
(j~1,2,    , 14) ð11Þ
where CPj denotes the number of drugs whose j-th order predicted
ATC-class is one of the true ATC-class, and N denotes the total
number of query drugs whose ATC-classes are to be identified.
According to such a definition, the result of higher ACj with smaller
j or lower ACj with larger j indicates that the predicted hits are
more concentrated meaning a better prediction. Obviously, the
result with high 1
st-order prediction accuracy AC1 always
represents a good quality of prediction.
The average number of ATC-classes for the N query drugs is
defined as
AN~
P N
i~1
Ti
N
ð12Þ
where Ti is the number of ATC-classes for the i-th query drug.
Thus, another parameter for measuring the proportion of the true
classes successfully identified by the first m-order prediction hits
can be calculated as [13]
Lm~
P N
i~1
Pi,m
P N
i~1
Ti
ð13Þ
where Pi,m denotes the number of the first m predicted candidate
ATC-classes that are the true ATC-classes for the i-th drug in the
dataset. Usually, m could take the smallest integer that is equal to
or greater than AN; i.e.,
ATC Classification of Drugs
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AN,i fAN is an integer
1zInt AN ½  , otherwise
 
ð14Þ
where the operator Int means taking the integer part of the
quantity right after it. Again, the result of larger Lm with smaller m
implies a better prediction with less uncertainty.
Results and Discussion
For clarity, the original benchmark dataset S of 3,883 drugs (cf.
Supporting Information S1) can be separated into two subsets; i.e.,
S~S
(i)|S
(s) ð15Þ
where S
(i) contains 2,144 drugs that had the chemical-chemical
interaction information, while S
(s) contains (3,883{2,144)~
1,739 drugs that had no chemical-chemical interaction informa-
tion. Listed in Table 2 are the results obtained by the
aforementioned three different prediction methods in identifying
the 14 main ATC classes for the drugs investigated. By examining
the table, we can observe the following.
Performance of the Interaction-Based Method
For the 2,144 drugs in S
(i) we could use Eq.6 to conduct the
prediction. The results thus obtained are listed in column 2 of
Table 2, from which we can see that the 1st-order prediction by
the jackknife test on the 2,114 drugs was 67.72%. The success
rates generally followed a descending trend with increasing of the
order number, indicating that the predicted ATC-classes were well
sorted for each of the samples investigated. The average number of
the ATC-classes in S
(i) was AN~2664=2144~1:24 (see Eq.12).
Thus, it follows according to Eq.14 that m~2, meaning that the
first 2-order predictions should be taken into consideration.
Substituting these data into Eq.13, we obtained the overall
success rate by the predictions of the first two orders for the 2,144
drugs in S
(i) was Lm~71:51%, indicating that the interaction-
based method is quite promising in identifying the ATC-classed of
drugs. However, this method could only be used to deal with those
drugs that had the chemical-chemical interaction information.
Performance of Similarity-Based Method
For the remaining 1,739 drugs in the dataset S
(s) (cf. Eq.15)
that did not have the chemical-chemical information, the
similarity-based method (cf. Eq.10) was used as a backup, and
the results thus obtained are shown in column 3 of Table 2. It can
be seen from there that the 1
st-order prediction by the jackknife
test on the 1,739 drugs was 78.49%. The average number of ATC-
classes for the drugs in S
(s) was AN~2248=1739~1:29 (see
Eq.12), and hence we have m~2 (Eq.14), meaning that the first
2-order predictions should be taken into account. Substituting
these data into Eq.13, we obtained the overall success rate by the
first two orders predictions for the 1,739 drugs without the
chemical-chemical interaction information was 75.31%, indicating
that the similarity-based method was quite promising as well.
At a first glance at Table 2, it looks like that the success rates by
the similarity-based method (Eq.10) are higher than those by the
interaction-based method (Eq.6). However, since the success rates
by the two methods as reported in Table 2 were derived from two
different datasets, S
(i) and S
(s) (cf. Eq.15) respectively, they might
not able to reflect the true superiority between the two methods.
To make a comparison between them in a more fair manner, let us
construct a new dataset, denoted as S
(izs). It consists of 2,138
drugs with each containing both chemical-chemical interaction
and chemical-chemical similarity informations. The details of such
a dataset is given in Supporting Information S2.
Listed in Table 3 are the results obtained by the methods in
identifying the 14 main ATC classes for the 2,138 drugs in the
S
(izs)dataset. As we can see from the table, the 1
st-order
prediction accuracy by the interaction-based method was
67.40%, while that by the similarity-based method was 40.36%.
The average number of ATC-classes for the drugs in S
(izs) was
1.24 (see Eq.12), and hence we have m~2 (Eq.14), meaning that
the first 2-order predictions should be taken into account.
Substituting these data into Eq.13, we obtained the overall
success rate by the 1
st two orders predictions for the 2,138 drugs in
S
(izs) by the interaction-based method (Eq.6) was 71.26%, while
that by the similarity-based method (Eq.10) was only 43.69%,
indicating that the interaction-based method is superior to the
similarity-based method in identifying the ATC-classes of drugs.
That is why in the integrated method the first step was to use the
interaction method (Eq.6) to identify the ATC-classes for any
query drugs. When, and only when no meaningful result was
obtained by the interaction-based method, was the similarity-
based method (Eq.10) used as a backup to continue the prediction
(see the Section of ‘‘Prediction by Integrating the Interaction-
Based and Similarity-Based Methods’’).
Performance of Integrated Prediction Method
Shown in the 4
th column of Table 2 are the results obtained by
the integrated method in identifying the 14 main ATC classes for
the 3,883 drugs in the benchmark dataset S. As we can see there,
the 1
st-order prediction accuracy was 72.55%. The average
numbers of ATC-classes for the drugs in S was
AN~4912=3883~1:27 (see Eq.12). Thus, it follows according
to Eq.14 that m~2, meaning that the first 2-order predictions
Table 2. The jackknife success rates by three different
methods in identifying the drugs among the 14 main ATC-
classes.
Prediction order Interaction-based
a Similarity-based
b Integrated
c
1 67.72% 78.49% 72.55%
2 21.13% 18.86% 20.11%
3 13.43% 8.63% 11.28%
4 7.18% 5.23% 6.31%
5 4.76% 2.88% 3.91%
6 3.54% 1.73% 2.73%
7 1.63% 0.12% 0.95%
8 0.75% 0.35% 0.57%
9 0.75% 0.12% 0.46%
10 0.56% 0.06% 0.33%
11 0.09% 0.00% 0.05%
12 0.28% 0.00% 0.15%
13 0.09% 0.00% 0.05%
14 0.05% 0.00% 0.03%
aUsing Eq.6 on the 2,144 drugs in the benchmark dataset S that had the
chemical-chemical interaction information.
bUsing Eq.10 on the 3,883{2,144~1,739 drugs in the benchmark dataset S
that had no chemical-chemical interaction information.
cUsing the integrated method by hybridizing Eq.6 and Eq.10 on the 3,883
drugs in the benchmark dataset S as given in Supporting Information S1.
doi:10.1371/journal.pone.0035254.t002
ATC Classification of Drugs
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35254should be taken into consideration. Substituting these data into
Eq.13, we obtained the overall success rate by the first two orders
predictions for the drugs in S was 73.25%.
These results indicate that the integrated method performed
quite well in identifying drugs among their 14 main ATC-classes,
and that more attention should be paid to the results hit by the first
two order predictions because they covered more than 70% of the
true ATC-classes.
Finally, it is instructive to point out that although the above
demonstrations were given for identifying query drug compounds
among their main (or 1
st level) classification, the method developed
here can be straightforwardly extended to cover the 2
nd,3
rd,4
th,
5
th or any lower-level classification as long as the corresponding
statistically significant datasets for training the predictor are
available.
Supporting Information
Supporting Information S1 List of the 4,376 drugs in the ATC
classification system extracted from KEGG.
(PDF)
Supporting Information S2 This dataset S
(izs) contains 2,138
drugs classified into 14 main ATC classes. Each of the drugs listed
here contains both chemical-chemical interaction and chemical-
chemical similarity informations. Among the 2,138 different drugs
(2,655 virtual drugs), 1,838 belong to one class; 190 to two classes;
57 to three classes, 19 to four classes, 14 to five classes, and 20 to
six classes. None of the drugs listed here belongs to seven and more
classes.
(PDF)
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